Literature DB >> 28546483

Finished Whole-Genome Sequences of Two Clostridium botulinum Type A(B) Isolates.

Jessica L Halpin1, Karen Hill2, Shannon L Johnson2, David Carlton Bruce2, T Brian Shirey3, Janet K Dykes3, Carolina Lúquez3.   

Abstract

Clostridium botulinum secretes a potent neurotoxin that causes devastating effects when ingested, including paralysis and death if not treated. In the United States, some clinically significant strains produce toxin type A while also harboring a silent B gene. These are the first two closed genome sequences published for this subset.
Copyright © 2017 Halpin et al.

Entities:  

Year:  2017        PMID: 28546483      PMCID: PMC5477396          DOI: 10.1128/genomeA.00381-17

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Many Clostridium botulinum type A strains isolated in the United States also harbor a silent toxin type B gene (bont/B) (our unpublished data). These strains have been difficult to distinguish by traditional subtyping methods, such as pulsed-field gel electrophoresis or multilocus variable-number tandem-repeat analysis (1–8). As whole-genome sequencing has become more accessible to public health laboratories, it is vital to have representative closed genome sequences for clinically relevant strain populations. Here, we present two finished genome sequences containing a bont/A1 gene and the unexpressed bont/B5 gene. A hybrid assembly method was utilized, and both isolates were sequenced by Illumina and PacBio and then assembled using Velvet 1.2.08, HGAP 3, and Phrap 4.24. The coverages for strain CDC69094 were 263× by PacBio and 309× by Illumina. The coverages for strain CDC67190 were 334× by PacBio and 310× by Illumina. CDC67190 was isolated from patient stool in the course of a foodborne outbreak investigation. The finished genome included 2 plasmids, pNPD12_1 (accession no. CP014146), with 5,926 bp, and pNPD12_2 (accession no. CP014147), with 59,360 bp. These plasmids contain 6 and 109 coding regions, respectively. The chromosome has 3,954,777 bp and includes 3,602 coding regions and a G+C content of 28.2%. Both toxin genes were found in the chromosome rather than on the plasmids. CDC69094 was isolated from a stool specimen from an infant botulism case. Interestingly, this genome did not include a plasmid, indicating that the unexpressed B gene is contained on the chromosome with the toxin type A gene. The chromosome (accession no. CP013246) included 4,089,027 bp, a G+C content of 28.1%, and 3,711 coding regions.

Accession number(s).

The finished sequences have been deposited in GenBank, under accession no. CP013246 for CDC69094 and accession numbers CP014146, CP014147, and CP014148 for CDC67190.
  8 in total

Review 1.  Historical and current perspectives on Clostridium botulinum diversity.

Authors:  Theresa J Smith; Karen K Hill; Brian H Raphael
Journal:  Res Microbiol       Date:  2014-10-12       Impact factor: 3.992

2.  Phylogenetic analysis of Clostridium botulinum type A by multi-locus sequence typing.

Authors:  Mark J Jacobson; Guangyun Lin; Thomas S Whittam; Eric A Johnson
Journal:  Microbiology       Date:  2008-08       Impact factor: 2.777

3.  Whole-genome single-nucleotide-polymorphism analysis for discrimination of Clostridium botulinum group I strains.

Authors:  Narjol Gonzalez-Escalona; Ruth Timme; Brian H Raphael; Donald Zink; Shashi K Sharma
Journal:  Appl Environ Microbiol       Date:  2014-01-24       Impact factor: 4.792

Review 4.  Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins.

Authors:  M D Collins; A K East
Journal:  J Appl Microbiol       Date:  1998-01       Impact factor: 3.772

5.  Genetic homogeneity of Clostridium botulinum type A1 strains with unique toxin gene clusters.

Authors:  Brian H Raphael; Carolina Luquez; Loretta M McCroskey; Lavin A Joseph; Mark J Jacobson; Eric A Johnson; Susan E Maslanka; Joanne D Andreadis
Journal:  Appl Environ Microbiol       Date:  2008-05-23       Impact factor: 4.792

6.  Genetic characterization of Clostridium botulinum type A containing silent type B neurotoxin gene sequences.

Authors:  R A Hutson; Y Zhou; M D Collins; E A Johnson; C L Hatheway; H Sugiyama
Journal:  J Biol Chem       Date:  1996-05-03       Impact factor: 5.157

7.  Evidence that plasmid-borne botulinum neurotoxin type B genes are widespread among Clostridium botulinum serotype B strains.

Authors:  Giovanna Franciosa; Antonella Maugliani; Concetta Scalfaro; Paolo Aureli
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

8.  Distinguishing highly-related outbreak-associated Clostridium botulinum type A(B) strains.

Authors:  Brian H Raphael; Timothy B Shirey; Carolina Lúquez; Susan E Maslanka
Journal:  BMC Microbiol       Date:  2014-07-16       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.